Dania Pagarkar joins Ethics Talk to discuss her article, coauthored with Drs Erin Harrop and Lisa Erlanger: “How Should We Approach Body Size Diversity in Clinical Trials?”
Marcia C. Inhorn, PhD, MPH and Pasquale Patrizio, MD, MBE
Low-cost in vitro fertilization (LCIVF) is better than no infertility treatment in countries that prohibit adoption and third-party reproductive assistance.
AMA J Ethics. 2018;20(3):228-237. doi:
10.1001/journalofethics.2018.20.3.ecas1-1803.
Patients seeking IVF are highly motivated to become parents and may wish to preserve financial resources for surrogacy or adoption should IVF not succeed, so risk sharing appeals to them, which makes its high cost especially problematic.
Donna T. Chen, MD, MPH, Lois Shepherd, JD, and Daniel M. Becker, MD, MPH, MFA
When most statutes about confidential treatment of adolescents were adopted, immunization against sexually transmitted infection was not anticipated, so the statutes contain no specific inclusion of such preventive measures.
AMA Journal of Ethics editor Audiey Kao, MD, PhD, interviewed Richard Pan, MD, MPH, about how, as a physician and legislator, he seeks to protect public health in light of recurrent outbreaks of vaccine-preventable infectious diseases.
When deciding whether to provide assisted reproductive services to a postmenopausal woman, the doctor must consider the well-being of the future child but not put social concerns above the individual patient's interests.